Emergency Ventilator Splitting Between Two or More Patients (COVID-19)
NCT ID: NCT04381013
Last Updated: 2021-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-06-30
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Flow Controlled Ventilation in ARDS Associated With COVID-19
NCT04399317
Treating COVID-19 With a Bidirectional Oxygenation Valve
NCT04326452
EASiVENT Study Comparing INTELLiVENT-ASV vs Non Automated Ventilation in Adult ICU Patients
NCT04400643
Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients
NCT04681859
Ventil Device Usefulness in Mechanically Ventilated ICU Patients
NCT04355754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1: Routine surgery
As part of routine cardio-thoracic surgery, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 1 minute.
Emergency Ventilator Splitter
Device to enable oxygen delivery to two patients independently from a single ventilator.
Phase 2: ECHO treatment
During care with Extracorporeal Membrane Oxygenation (ECMO) for non-SARS-CoV-2, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 24 hours.
Emergency Ventilator Splitter
Device to enable oxygen delivery to two patients independently from a single ventilator.
Phase 3: COVID-19 treatment
Endotracheal tubes split from ventilator delivering oxygen independently to two patients with COVID-19 disease for up to 1 hour.
Emergency Ventilator Splitter
Device to enable oxygen delivery to two patients independently from a single ventilator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emergency Ventilator Splitter
Device to enable oxygen delivery to two patients independently from a single ventilator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing routine thoracic surgery which will include the use of a dual lumen endotracheal tube at Stanford.
* Phase II
* Able to give consent
* On venovenous extracorporeal membrane oxygenation for reason other than COVID-19
* Phase III
* Able to give consent
* Infected with COVID-19 and will likely require mechanical ventilation.
Exclusion Criteria
* Significant cardiac comorbidities
* Liver disease
* Phase II
* Significant cardiac comorbidities
* Pre or Post-transplant patient
* Infection with COVID-19
* Phase III
* Co-infection with disease aside from COVID-19
* Severely ill requiring high ventilator requirements and not stable for ventilator splitting
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Woo, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
57573
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.